THRD: Third Harmonic Bio O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Third Harmonic Bio (THRD) ning barqaror boshqaruvi immunologik portfelini kengaytirgan holda qat'iy moliyaviy siyosatni olib bormoqda. PEG koeffitsiyentini kuzatish joriy biznes baholashini ko'rsatadi, bunda 0.00 metriki parametr holatini belgilaydi. THB001 dori vositasining teri patologiyalarini davolashdagi muvaffaqiyatlari ijobiy dinamika yaratmoqda, yetakchi immunologlarning jalb qilinishi esa noyob ilmiy asos tufayli allergiya davolashda sifatli yuksalishni ta'minlaydi.
Third Harmonic Bio (THRD) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Third Harmonic Bio|THRD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi thirdharmonicbio.com|THRD - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Third Harmonic Bio, Inc|THRD - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Third Harmonic Bio|Oraliq qoplash koeffitsiyenti thirdharmonicbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
THRD - Sof foyda|Kompaniya foydasi prognozi Third Harmonic Bio|THRD - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Third Harmonic Bio Inc|THRD - PEG multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Third Harmonic Bio, Inc|THRD - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Third Harmonic Bio|THRD - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi thirdharmonicbio.com|THRD - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Third Harmonic Bio
Kompaniyaning umumiy tahlili:THRD - Third Harmonic Bio Inc.
Third Harmonic Bio (THRD) ning molekulalar sintezini sertifikatlangan CMO zavodlariga topshiruvchi fabless modeli xarajatlarni optimallashtiradi va ishlab chiqarish to'xtab qolishi risklarini kamaytiradi. Ushbu operatsion afzalliklar PEG koeffitsiyentiga aks etadi, u joriy narx biznes dinamikasiga nisbatan past baholanganini aniqlash uchun P/E koeffitsiyentini foyda o'sish sur'atlari bilan bog'laydi; birdan past qiymat aktivning fundamental jihatdan past baholanganligidan dalolat beradi.
Third Harmonic Bio kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|Pharvaris Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ABCL: PEG multiplikatori|tourmalinebio.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PGEN (Precigen) - PEG multiplikatori|Pharming Group NV (PHAR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KALV (KalVista Pharma)|SEPN: PEG multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|PEG multiplikatori rigel.com|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT - Narx-foyda va o‘sish multiplikatori|JBIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda aclaristx.com|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TLSA|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AGEN|Climb Bio, Inc. - PEG multiplikatori|ZURA: Narxning foydaga va o‘sish sur’atiga nisbati|ATYR: PEG multiplikatori|ADAG - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|O‘sish sur’atiga tuzatilgan narx-foyda Shattuck Therapeutics STTK|Narx-foyda va o‘sish multiplikatori EQ (Equillium, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati CNTB|PEG multiplikatori IMUX (Immunic)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ATRA|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XFOR (X4 Pharmaceuticals Inc.)|ACET: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CELU|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|barinthusbio.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori KZR|SABS (SAB Biotherapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AKTX (Akari Therapeutics plc)|PEG multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GOVX (geovax.com)|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori iBio Inc|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|PEG multiplikatori XTL Bio|Narx-foyda va o‘sish multiplikatori BOLT (Bolt Biotherapeutics)|HCWB (hcwbiologics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aimimmuno.com (AIM)|ADTX - Narxning foydaga va o‘sish sur’atiga nisbati|GRI Bio Corporation (GRI) - Narx-foyda va o‘sish multiplikatori|XORTX Therapeutics Inc. (XRTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori reshapelifesciences.com|Narx-foyda va o‘sish multiplikatori REVB|PEG multiplikatori Indaptus Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|calcimedica.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AFMD (Affimed N.V.)|Allakos Inc (ALLK) - O‘sish sur’atiga tuzatilgan narx-foyda|HOOK: Narx-foyda va o‘sish multiplikatori|IGM Biosciences, Inc. - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ITOS: PEG multiplikatori|Ocean Biomedical Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|TCBP (TC Biopharm) - PEG multiplikatori
